Patents by Inventor Ai Minomo

Ai Minomo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bilirubin excretion enhancer
    Patent number: 9744217
    Abstract: The purpose of the present invention is to establish a novel therapy method for hyperbilirubinemia and therefore, to provide a bilirubin excretion enhancer. The present invention provides a bilirubin excretion enhancer comprising, as an active ingredient, a serum albumin domain II-like protein comprising a serum albumin subdomain IIA. In one embodiment, the serum albumin subdomain IIA has an amino acid sequence of SEQ ID NO: 1. in one embodiment, the serum albumin domain II-like protein is a serum albumin domain II. In one embodiment, the serum albumin domain II comprises the amino acid sequence of SEQ ID NO: 4.
    Type: Grant
    Filed: October 7, 2015
    Date of Patent: August 29, 2017
    Assignee: Nipro Corporation
    Inventors: Masaki Otagiri, Toru Maruyama, Yu Ishima, Ai Minomo
  • "Bilirubin Excretion Enhancer"
    Publication number: 20160058844
    Abstract: The purpose of the present invention is to establish a novel therapy method for hyperbilirubinemia and therefore, to provide a bilirubin excretion enhancer. The present invention provides a bilirubin excretion enhancer comprising, as an active ingredient, a serum albumin domain II-like protein comprising a serum albumin subdomain IIA. In one embodiment, the serum albumin subdomain IIA has an amino acid sequence of SEQ ID NO: 1. in one embodiment, the serum albumin domain II-like protein is a serum albumin domain II. In one embodiment, the serum albumin domain II comprises the amino acid sequence of SEQ ID NO: 4.
    Type: Application
    Filed: October 7, 2015
    Publication date: March 3, 2016
    Inventors: Masaki Otagiri, Toru Maruyama, Yu Ishima, Ai Minomo
  • Bilirubin Excretion Enhancer
    Publication number: 20140187744
    Abstract: The purpose of the present invention is to establish a novel therapy method for hyperbilirubinemia and therefore, to provide a bilirubin excretion enhancer. The present invention provides a bilirubin excretion enhancer comprising, as an active ingredient, a serum albumin domain II-like protein comprising a serum albumin subdomain IIA. In one embodiment, the serum albumin subdomain IIA has an amino acid sequence of SEQ ID NO: 1. In one embodiment, the serum albumin domain II-like protein is a serum albumin domain II. In one embodiment, the serum albumin domain II comprises the amino add sequence of SEQ ID NO: 4.
    Type: Application
    Filed: August 9, 2012
    Publication date: July 3, 2014
    Applicant: NIPRO CORPORATION
    Inventors: Masaki Otagiri, Toru Maruyama, Yu Ishima, Ai Minomo